Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06ANS
|
|||
| Former ID |
DIB014333
|
|||
| Drug Name |
CVBT-141H
|
|||
| Synonyms |
CVBT-141A; CVBT-141C; CVBT-141C); Cardio Vascu-Grow; FGF-1-141; Recombinant FGF-1 (coronary heart disease), CardioVascular Therapeutics; Recombinant FGF-1 (peripheral vascular disease), CardioVascular biotherapeutics
Click to Show/Hide
|
|||
| Indication | Coronary artery disease [ICD-11: BA80; ICD-10: I25.1, I25.4] | Phase 2 | [1] | |
| Coronary heart disease [ICD-11: BA80.Z; ICD-9: 414] | Phase 2 | [2] | ||
| Peripheral arterial disease [ICD-11: BD4Z; ICD-10: I73, I73.9] | Phase 2 | [2] | ||
| Company |
CardioVascular BioTherapeutics Inc; CardioVascular Biotherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020529) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of CVBT. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.